IRVING, Texas and NEW YORK, April 18, 2025 /PRNewswire/ -- Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company with over $140 billion in annual purchasing ...

Without a biopsy, it’s difficult to determine whether a woman has breast cancer. But biopsies are costly and invasive – and often, in women with fibrous breast tissue and no cancer – they’re actually ...

Company to ramp up marketing efforts for Provista’s automated capabilities for COVID-19 PCR testing, variant identification, and neutralizing antibody testing NEW YORK, NY, and TEL AVIV, ISRAEL, Aug.

REHOVOT, Israel, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection of ...

DURHAM, N.C.--(BUSINESS WIRE)--PatientPay, the leading patient billing and payments partner for acute, ambulatory and specialty care, today announced it has been awarded a contract from Provista, a ...

Provista, the nation’s largest non-acute healthcare group purchasing organization, selected CHCollective among other potential community health center channels. Says Micah Smith, General Manager with ...

NEW YORK, March 1, 2016 /PRNewswire/ -- Provista Diagnostics Inc., a company developing and commercializing proteomic-based diagnostic, prognostic and monitoring tests for cancers affecting women, has ...

NEW YORK, July 07, 2016 (GLOBE NEWSWIRE) -- Provista Diagnostics, a private company developing and commercializing protein-based diagnostic, prognostic and monitoring tests for cancers affecting women ...

Provista has announced it is collaborating with Medline Industries on a program aimed at helping home care and hospice agencies with reimbursement cuts, according to a Provista news release. The ...

EL SEGUNDO, Calif.--(BUSINESS WIRE)--PCM, Inc. (PCMI), a leading technology solutions provider, today announced that its UK-based subsidiary, PCM Technology Solutions UK, Ltd. (PCM UK), has acquired ...

Company to ramp up marketing efforts for Provista’s automated capabilities for COVID-19 PCR testing, variant identification, and neutralizing antibody testing Todos is currently expanding Provista’s ...